Markets:

Overview

News

Currencies

International

Treasuries

Precigen, Inc. - Common Stock (NQ:PGEN)

3.180 -0.090 (-2.75%)

Streaming Delayed Price Updated: 9:34 AM EDT, Mar 19, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Precigen, Inc. - Common Stock

< Previous 1 2 3 4 5 6 Next >

Earnings Preview For Precigen ↗

March 03, 2023

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday ↗

March 03, 2023

We're starting off Friday morning with a breakdown of the biggest pre-market stock movers traders need to keep an eye on!

Via InvestorPlace

3 Penny Stocks The Insiders Are Buying

February 28, 2023

The insiders are buying these penny stocks with support from analysts and institutions. Could they be the next big winners?

Via MarketBeat

Topics Intellectual Property

Why Altimmune, Foghorn Therapeutics, and Precigen Shares Crashed This Week ↗

February 16, 2023

Concerns about a tough financing environment weighed on clinical-stage biotech stocks this week.

Via The Motley Fool

Precigen Earnings Perspective: Return On Capital Employed ↗

December 15, 2022

Via Benzinga

Precigen Is Pioneering a Nonsurgical Treatment for a Debilitating Respiratory Disease; Positive Data Released on Recurrent Respiratory Papillomatosis Showed a 50% Complete Response ↗

February 07, 2023

New hope may be on the horizon for sufferers of Recurrent Respiratory Papillomatosis, or RRP, a rare and debilitating disease that typically requires patients to undergo multiple surgeries each year to...

Via Benzinga

Precigen Is Pioneering a Nonsurgical Treatment for a Debilitating Respiratory Disease; Positive Data Released on Recurrent Respiratory Papillomatosis Showed a 50% Complete Response

February 07, 2023

Precigen Is Pioneering a Nonsurgical Treatment for a Debilitating Respiratory Disease; Positive Data Released on Recurrent Respiratory Papillomatosis Showed a 50% Complete Response

Via News Direct

$20 Million Bet On Precigen? Check Out These 4 Penny Stocks Insiders Are Buying ↗

February 01, 2023

The Dow Jones jumped more than 350 points on Tuesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in...

Via Benzinga

Benzinga's 'Stock Whisper' Index: 5 Stocks Investors Are Secretly Monitoring, But Not Yet Talking About ↗

January 26, 2023

Investors are on the hunt for undervalued, underfollowed and emerging stocks to spot opportunities. Retail traders have countless methods at their disposal to uncover new information. For some, this...

Via Benzinga

Nasdaq Falls 50 Points; eHealth Shares Spike Higher ↗

January 25, 2023

U.S. stocks traded lower toward the end of trading, with the Nasdaq Composite dropping around 50 points on Wednesday. The Dow traded down 0.12% to 33,694.64 while the NASDAQ fell 0.44% to 11,284.18....

Via Benzinga

Why Grom Social Enterprises Shares Are Trading Lower By 30%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session ↗

January 25, 2023

Gainers Sonoma Pharmaceuticals, Inc. (NASDAQ: SNOA) shares surged 85% to $2.2200. Sonoma Pharmaceuticals and EMC Pharma announced Department of Defense DAPA registration for Microcyn(R) Rx products.

Via Benzinga

Nasdaq Down Over 200 Points; AT&T Posts Upbeat Earnings ↗

January 25, 2023

U.S. stocks traded lower midway through trading, with the Nasdaq Composite dropping more than 200 points on Wednesday. The Dow traded down 1.10% to 33,364.09 while the NASDAQ fell 1.92% to 11,116.96....

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

January 25, 2023

Via Benzinga

US Stocks Open Lower; Dow Dips 250 Points ↗

January 25, 2023

U.S. stocks traded lower this morning, with the Dow Jones dropping around 250 points on Wednesday. Following the market opening Wednesday, the Dow traded down 0.74% to 33,484.47 while the NASDAQ fell...

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

January 25, 2023

Via Benzinga

Why eHealth Shares Are Trading Higher By Over 18%; Here Are 20 Stocks Moving Premarket ↗

January 25, 2023

Gainers Inpixon (NASDAQ: INPX) shares rose 41% to $2.20 in pre-market trading after gaining 6% on Tuesday. Inpixon, last month, secured a purchase order valued at over $1m for its RTLS products from a...

Via Benzinga

3 Penny Stocks That Could Make You Filthy Rich ↗

January 25, 2023

These low-priced equities could deliver enormous returns for risk-tolerant shareholders.

Via The Motley Fool

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday ↗

January 25, 2023

It's time to start off the day with an overview of the biggest pre-market stock movers traders need to know about on Wednesday!

Via InvestorPlace

Intuitive Surgical, Microsoft And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session ↗

January 25, 2023

U.S. stock futures traded lower this morning. Here are some big stocks recording losses in today’s pre-market trading session.

Via Benzinga

12 Health Care Stocks Moving In Tuesday's After-Market Session ↗

January 24, 2023

Via Benzinga

Precigen’s Overnight Cell Manufacturing Technology Could Offer Advanced AML Patients The Option Of Promising CAR-T Therapy

December 27, 2022

By Faith Ashmore, Benzinga

Via News Direct

Topics Death

Precigen’s Overnight Cell Manufacturing Technology Could Offer Advanced AML Patients The Option Of Promising CAR-T Therapy

December 27, 2022

Acute myeloid leukemia (AML) is among the most common types of leukemia in adults. The term leukemia refers to cancers of the bone marrow and blood cells. Doctors refer to AML as “acute” because the...

Via TheNewswire.com

Topics Death

12 Health Care Stocks Moving In Monday's After-Market Session ↗

December 19, 2022

Via Benzinga

Precigen's Overnight Cell Manufacturing Technology Could Offer Advanced AML Patients The Option Of Promising CAR-T Therapy ↗

December 08, 2022

-Clinical Data Due Next Week at ASH-

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For November 18, 2022 ↗

November 18, 2022

Upgrades

Via Benzinga

Why Apyx Medical Shares Dipped Over 60%; Here Are 123 Biggest Movers From Yesterday ↗

November 11, 2022

Gainers

Via Benzinga

A Preview Of Precigen's Earnings ↗

November 08, 2022

Precigen (NASDAQ:PGEN) is set to give its latest quarterly earnings report on Wednesday, 2022-11-09. Here's what investors need to know before the announcement. Analysts estimate that Precigen will...

Via Benzinga

Why NVIDIA, Microsoft And Amazon Shares Traded Lower; Here Are 73 Biggest Movers From Friday ↗

October 10, 2022

Gainers Innovative Eyewear, Inc. (NASDAQ: LUCY) climbed 61.4% to close at $2.63 on abnormally-high volume. The company released its October investor presentation yesterday.

Via Benzinga

Why Stabilis Solutions Shares Jumped Over 71%; Here Are 70 Biggest Movers From Yesterday ↗

September 22, 2022

Gainers

Via Benzinga

Looking Into Precigen's Return On Capital Employed ↗

August 31, 2022

According to Benzinga Pro data, during Q2, Precigen (NASDAQ:PGEN) posted sales of $2.91 million. Earnings were up 8.39%, but Precigen still reported an overall loss of $17.64 million.

Via Benzinga

< Previous 1 2 3 4 5 6 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.